News for Inogen, Inc. (INGN)

\n[url=\

\n Inogen Inc. (INGN) will announce its Q1 2025 financial results on May 7, 2025, post-market close. A conference call discussing the results is scheduled

BOSTON, April 15, 2025 /PRNewswire/ -- Below is the March 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE:ASG).

Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

[url="]Inogen, Inc.[/url] (Nasdaq: [url="]INGN[/url]), a medical technology company offering innovative respiratory products for use in the homecare setting, t

Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Expanding product portfolio and high prospects for POC raise optimism for INGN stock

On March 3, 2025, Smith Kevin Raymond Merrill, CEO and President of Inogen Inc, purchased 11,709 shares of Inogen Inc (INGN). Following this transaction, the in

On March 3, 2025, Michael Bourque, Executive Vice President, Chief Financial Officer & Treasurer of Inogen Inc, purchased 3,000 shares of the company. Following

Inogen shows solid B2B growth, but guidance and margin issues hurt sentiment. Learn why INGN stock is a speculative play with long-term growth potential.

Total Revenue (Q4 2024): $80.1 million, a 5.5% increase year-over-year.Domestic B2B Revenue (Q4 2024): $22.4 million, a 24.1% increase year-over-year.Internati

Feb 25, 2025 / 10:00PM GMTOperator Welcome to Inogen's fourth-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is b

Inogen, Inc. (NASDAQ:INGN) Q4 2024 Earnings Conference Call February 25, 2025 5:00 PM ETCompany ParticipantsRyan Peterson – Investor RelationsKevin Smith –...

The following slide deck was published by Inogen, Inc.

Inogen (INGN) delivered earnings and revenue surprises of 28.07% and 0.73%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Quarterly Revenue: $80.1 million, surpassing the estimated $73.91 million, reflecting a 5.5% increase year-over-year.Quarterly EPS: Reported at -$0.41, outperf

[url="]Inogen, Inc.[/url] (Nasdaq: [url="]INGN[/url]), a medical technology company offering innovative respiratory products for use in the homecare setting, t

Fresenius Medical, Masimo, Merit Medical Systems and Inogen are included in this Analyst Blog.

Inogen Inc (INGN) is set to release its Q4 2024 earnings on Feb 25, 2025. The consensus estimate for Q4 2024 revenue is $73.91 million, and the earnings are exp